Check Before You Invest : Emmessar Biotech & Nutrition Ltd

Snapshot

Q.1 Which industry/sub-sector does Emmessar Biotech & Nutrition Ltd belong to?

Emmessar Biotech & Nutrition Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Emmessar Biotech & Nutrition Ltd a good quality company?

Emmessar Biotech & Nutrition Ltd is a quality company, based on a 10-year financial track record.

Q.3 Is Emmessar Biotech & Nutrition Ltd undervalued or overvalued?

Emmessar Biotech & Nutrition Ltd appears Somewhat Undervalued, as its key valuation ratios are below with their past averages.

Q.4 Is Emmessar Biotech & Nutrition Ltd a good buy now?

Emmessar Biotech & Nutrition Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd revenue growth is 8.9% for FY-2025, which is above its 5-year CAGR of -29.08%, indicating faster growth.

Q.2 Return on capital employed (ROCE) of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Return on capital employed is 12.63% for FY-2025, which is below its 5-year historical median of 14.99%. The current ROCE is below its estimated weighted average cost of capital (WACC) of 14%, indicating value preservation.

Q.3 Return on Asset of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Return on Asset is 3.48%, which is below its 5-year historical median of 6.42%, indicating deteriorated asset utilization efficiency.

Q.4 Return on Equity (ROE) of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Return on equity is 4.19% for FY-2025, which is below its 5-year historical median of 8.01%, indicating the business is making worse use of its shareholders capital.

Q.5 Cash conversion cycle of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Cash conversion cycle is 74 days, in line with its 5-year historical median of 74 days, indicating stable working capital management. However, you need to compare this with its peers in the industry.

	Current Level	5-year Historic Median
Asset Turnover	0.07	0.07
ROE	4.19	8.01
ROCE	12.63	14.99
Cash Conversion Cycle	74 days	74 days

Q.6 Gross Profit margin of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Gross profit margin which is the profit after deduction of direct costs, is 172.8% for FY-2025, which is above its 5-year median of 163.9%, indicating increasing margins.

Q.7 Operating Profit Margin of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is -155.51% for FY-2025, which is in line with its 5-year median of -155.51% indicating stable margins.

Q.8 Net Profit Margin of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Net Profit Margin is 51.76% for FY-2025, is in line with with its 5-year median of 51.76%, indicating stable margins.

	Current Level	5-year Historic Median
Gross Profit Margin	172.8	163.9
Operating Profit Margin	-155.51	-155.51
Net Profit Margin	51.76	51.76

Q.9 Debt to Equity ratio of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Debt-to-Equity ratio is 0.00, which is lower with the industry average of 0.27, indicating lower debt levels in the industry.

Q.10 Debt to cash flow from operations of Emmessar Biotech & Nutrition Ltd?

Emmessar Biotech & Nutrition Ltd Debt to cash flow from operations is 0, which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Emmessar Biotech & Nutrition Ltd?

Promoters hold 59.53% of the Emmessar Biotech & Nutrition Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Emmessar Biotech & Nutrition Ltd vs industry peers?

Emmessar Biotech & Nutrition Ltd revenue CAGR is -29.08%, compared to the industry median CAGR of 8.30%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	5-year Industry Median
Revenue Growth	8.9	8.3
Gross Profit Growth	16.5	14.7
Operating Profit Growth	0	11.4
Net Profit Growth	-57.3	NAN

Operating Efficiency

	Current Level	5-year Industry Median
Asset Turnover	0.07	0.81
ROE	4.19	9.49
ROCE	12.63	11.91
Cash Conversion Cycle (days)	74.02	85

Valuation & price assessment

Q.1 Stock return of Emmessar Biotech & Nutrition Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 7.7% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	7.7%	2.8%	1%	-30.3%

Q.3 Valuation ratios of Emmessar Biotech & Nutrition Ltd vs historical?

The current P/E is higher that its historical median.

Q.4 How do the current valuation ratios compare with 5-year historical median and industry numbers?

Valuation Ratios	Current	5-year Historic Median	5-year Industry Median
Price to Earnings	38.07	26.38	31.09
Price to Book	1.56	2.12	2.85
Price to Sales	33.8	22.89	2.79
EV to EBITDA	6.33	7.88	15.87

Check more companies

5. Wockhardt

9. Pfizer

10. Neuland Laboratories

Check trending companies

1. JSW Infrastructure Ltd.

2. Aditya Birla Fashion and Retail Ltd.

3. Zydus Lifesciences Ltd.

4. Techno Electric & Engineering Company Ltd.

5. Cello World Ltd.